Location: Stockholm, Sweden
CIK: 0002003159 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 4, 2026
Total Value: $16.54M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| NMRK | NEWMARK GROUP INC | 200,493 | $3.477M | 21.0% | $17.34 | $16.26 | +6.6% | CL A | 65158N102 |
| CI | THE CIGNA GROUP | 11,818 | $3.253M | 19.7% | $275.23 | $279.23 | -1.4% | COM | 125523100 |
| ARVN | ARVINAS INC | 166,342 | $1.973M | 11.9% | $11.86 | $10.92 | +8.6% | COM | 04335A105 |
| ABVX | ABIVAX SA | 14,375 | $1.939M | 11.7% | $134.86 | $109.11 | +23.6% | SPONSORED ADS | 00370M103 |
| IQV | IQVIA HLDGS INC | 8,183 | $1.845M | 11.1% | $225.41 | $217.58 | +3.6% | COM | 46266C105 |
| MRVI | MARAVAI LIFESCIENCES HLDGS I | 457,707 | $1.488M | 9.0% | $3.25 | $3.37 | -3.5% | COM CL A | 56600D107 |
| BDX | BECTON DICKINSON & CO | 5,176 | $1.005M | 6.1% | $194.07 | $189.05 | +2.7% | COM | 075887109 |
| — | ATAI BECKLEY NV | 234,915 | $961K | 5.8% | $4.09 | $4.09 | — | SHS | N0731H103 |
| SLNO | SOLENO THERAPEUTICS INC | 8,741 | $405K | 2.4% | $46.30 | $54.83 | -15.6% | COM | 834203309 |
| KLTO | KLOTHO NEUROSCIENCES INC | 606,757 | $175K | 1.1% | $0.29 | $0.48 | -39.8% | COM | 49876K103 |
| FHTX | FOGHORN THERAPEUTICS INC | 4,708 | $25,423 | 0.2% | $5.40 | $4.53 | +19.1% | COM | 344174107 |